In another cohort of 29 advanced NSCLC patients treated with anti-PD1/PD-L1 monotherapy, Shukuya et al. identified seven EV-associated miRNAs that had significant concentration differences between responders and non-responders at baseline. Here, CD274 is linked to non-small cell lung carcinoma.